{"id":"https://openalex.org/W3213035874","doi":"https://doi.org/10.1016/j.cellsig.2021.110185","title":"Phosphodiesterase 4 inhibitors in diabetic nephropathy","display_name":"Phosphodiesterase 4 inhibitors in diabetic nephropathy","publication_year":2021,"publication_date":"2021-11-14","ids":{"openalex":"https://openalex.org/W3213035874","doi":"https://doi.org/10.1016/j.cellsig.2021.110185","mag":"3213035874","pmid":"https://pubmed.ncbi.nlm.nih.gov/34785349"},"language":"en","primary_location":{"id":"doi:10.1016/j.cellsig.2021.110185","doi":"https://doi.org/10.1016/j.cellsig.2021.110185","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.cellsig.2021.110185","pdf_url":null,"source":{"id":"https://openalex.org/S113768434","display_name":"Cellular Signalling","issn_l":"0898-6568","issn":["0898-6568","1873-3913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cellular Signalling","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071184415","display_name":"Mitsugi Ookawara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsugi Ookawara","raw_affiliation_strings":["Extra-Value Generation and General Medicine DDU, Takeda Pharmaceutical Company, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Fujisawa city, Kanagawa 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Extra-Value Generation and General Medicine DDU, Takeda Pharmaceutical Company, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Fujisawa city, Kanagawa 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058742268","display_name":"Yasunori Nio","orcid":"https://orcid.org/0000-0002-2819-6207","observed_orcids":["https://orcid.org/0000-0002-2819-6207"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yasunori Nio","raw_affiliation_strings":["Extra-Value Generation and General Medicine DDU, Takeda Pharmaceutical Company, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Fujisawa city, Kanagawa 251-8555, Japan. Electronic address: yasunori.nio@takeda.com","Extra-Value Generation and General Medicine DDU, Takeda Pharmaceutical Company, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Fujisawa city, Kanagawa 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Extra-Value Generation and General Medicine DDU, Takeda Pharmaceutical Company, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Fujisawa city, Kanagawa 251-8555, Japan. Electronic address: yasunori.nio@takeda.com","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Extra-Value Generation and General Medicine DDU, Takeda Pharmaceutical Company, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-Chome, Fujisawa city, Kanagawa 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5058742268"],"corresponding_institution_ids":["https://openalex.org/I44892455"],"apc_list":{"value":2750,"currency":"USD","value_usd":2750},"apc_paid":null,"fwci":0.3058,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.24472546,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"90","issue":null,"first_page":"110185","last_page":"110185"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phosphodiesterase-4-inhibitors","display_name":"phosphodiesterase-4 inhibitors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.9850000143051147},{"id":"https://openalex.org/keywords/roflumilast","display_name":"roflumilast","score":0.8339999914169312},{"id":"https://openalex.org/keywords/pentoxifylline","display_name":"pentoxifylline","score":0.9959999918937683},{"id":"https://openalex.org/keywords/camp","display_name":"cyclic AMP","score":0.7979999780654907},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.7879999876022339},{"id":"https://openalex.org/keywords/renal-fibrosis","display_name":"renal fibrosis","score":0.7070000171661377},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7620000243186951},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.9679999947547913},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.5879999995231628},{"id":"https://openalex.org/keywords/kidney-disease","display_name":"kidney disease","score":0.5070000290870667},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8858376741409302},{"id":"https://openalex.org/C2778926808","wikidata":"https://www.wikidata.org/wiki/Q693482","display_name":"Roflumilast","level":3,"score":0.749902606010437},{"id":"https://openalex.org/C2781427535","wikidata":"https://www.wikidata.org/wiki/Q2858961","display_name":"Apremilast","level":4,"score":0.7022581100463867},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.547754168510437},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.5336288809776306},{"id":"https://openalex.org/C2780404050","wikidata":"https://www.wikidata.org/wiki/Q416331","display_name":"Pentoxifylline","level":2,"score":0.4812636077404022},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4709934592247009},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4624040722846985},{"id":"https://openalex.org/C62826618","wikidata":"https://www.wikidata.org/wiki/Q424304","display_name":"Phosphodiesterase","level":3,"score":0.4499810039997101},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.42797330021858215},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.4133566617965698},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3900197148323059},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.2699494957923889},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2372865378856659},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16817626357078552},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000242","descriptor_name":"Cyclic AMP","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054703","descriptor_name":"Cyclic Nucleotide Phosphodiesterases, Type 4","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D058988","descriptor_name":"Phosphodiesterase 4 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D058988","descriptor_name":"Phosphodiesterase 4 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.cellsig.2021.110185","doi":"https://doi.org/10.1016/j.cellsig.2021.110185","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.cellsig.2021.110185","pdf_url":null,"source":{"id":"https://openalex.org/S113768434","display_name":"Cellular Signalling","issn_l":"0898-6568","issn":["0898-6568","1873-3913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cellular Signalling","raw_type":"journal-article"},{"id":"pmid:34785349","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34785349","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cellular signalling","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":77,"referenced_works":["https://openalex.org/W1492748176","https://openalex.org/W1586904317","https://openalex.org/W1602546631","https://openalex.org/W1968726810","https://openalex.org/W1971740245","https://openalex.org/W1972029787","https://openalex.org/W1973163466","https://openalex.org/W1980647755","https://openalex.org/W1981227705","https://openalex.org/W1981969227","https://openalex.org/W1982341832","https://openalex.org/W1992234212","https://openalex.org/W2000977076","https://openalex.org/W2006254543","https://openalex.org/W2016802044","https://openalex.org/W2022218202","https://openalex.org/W2038510488","https://openalex.org/W2059605383","https://openalex.org/W2060554786","https://openalex.org/W2063270035","https://openalex.org/W2072797845","https://openalex.org/W2074422008","https://openalex.org/W2078575160","https://openalex.org/W2089006464","https://openalex.org/W2091510537","https://openalex.org/W2094719535","https://openalex.org/W2096271770","https://openalex.org/W2098642174","https://openalex.org/W2104479866","https://openalex.org/W2105156994","https://openalex.org/W2114456070","https://openalex.org/W2118748544","https://openalex.org/W2126919962","https://openalex.org/W2131523161","https://openalex.org/W2144557073","https://openalex.org/W2148158347","https://openalex.org/W2159269771","https://openalex.org/W2163333420","https://openalex.org/W2169097443","https://openalex.org/W2230518119","https://openalex.org/W2289487108","https://openalex.org/W2411987749","https://openalex.org/W2466234801","https://openalex.org/W2471976905","https://openalex.org/W2531364014","https://openalex.org/W2550737605","https://openalex.org/W2574720511","https://openalex.org/W2742862090","https://openalex.org/W2748024529","https://openalex.org/W2772222829","https://openalex.org/W2784619339","https://openalex.org/W2808536863","https://openalex.org/W2810048175","https://openalex.org/W2894569443","https://openalex.org/W2897240017","https://openalex.org/W2900376194","https://openalex.org/W2937955146","https://openalex.org/W2966771092","https://openalex.org/W2984666751","https://openalex.org/W2992970364","https://openalex.org/W2998710541","https://openalex.org/W2999939732","https://openalex.org/W3000427620","https://openalex.org/W3005184972","https://openalex.org/W3014570039","https://openalex.org/W3033331543","https://openalex.org/W3046417213","https://openalex.org/W3087136915","https://openalex.org/W3121122030","https://openalex.org/W3123809016","https://openalex.org/W3173001774","https://openalex.org/W3197675397","https://openalex.org/W3198761266","https://openalex.org/W4242560008","https://openalex.org/W6789180955","https://openalex.org/W6801175525","https://openalex.org/W6823803742"],"related_works":["https://openalex.org/W3121122030","https://openalex.org/W7034131892","https://openalex.org/W7117974990","https://openalex.org/W2901922481","https://openalex.org/W2897406695","https://openalex.org/W4313534951","https://openalex.org/W2053029072","https://openalex.org/W1981969227","https://openalex.org/W2605405094","https://openalex.org/W2049273984"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2021-11-22T00:00:00"}